1. Thomas ED, Lochte HL Jr, Lu WC, Ferrebee JW. Intravenous infusion of bone marrow in patients receiving radiation and chemotherapy. N Engl J Med. 1957; 257:491–496. PMID:
13464965.
Article
2. Hong R, Cooper MD, Allan MJ, Kay HE, Meuwissen H, Good RA. Immunological restitution in lymphopenic immunological deficiency syndrome. Lancet. 1968; 1:503–506. PMID:
4171200.
Article
3. Bollard CM, Krance RA, Heslop HE. Pizzo PA, Poplack DG, editors. Hematopoietic stem cell transplantation in pediatric oncology. Principles and practice of pediatric oncology. 2006. 5th ed. Philadelphia, USA: Lippincott Williams and Wilkins;p. 476–500.
4. Nowak J. Role of HLA in hematopoietic SCT. Bone Marrow Transplant. 2008; 42(Suppl 2):S71–S76. PMID:
18978750.
Article
5. Hauzenberger D, Schaffer M, Ringdén O, et al. Outcome of haematopoietic stem cell transplantation in patients transplanted with matched unrelated donors vs allele-mismatched donors: a single centre study. Tissue Antigens. 2008; 72:549–558. PMID:
19000143.
6. Crocchiolo R, Ciceri F, Fleischhauer K, et al. HLA matching affects clinical outcome of adult patients undergoing haematopoietic SCT from unrelated donors: a study from the Gruppo Italiano Trapianto di Midollo Osseo and Italian Bone Marrow Donor Registry. Bone Marrow Transplant. 2009; 44:571–577. PMID:
19363528.
Article
7. Weisdorf DJ, Nelson G, Lee SJ, et al. Sibling versus unrelated donor allogeneic hematopoietic cell transplantation for CML: refined HLA-matching shows more GVHD but not less relapse. Biol Blood Marrow Transplant. 2009; 15:1475–1478. PMID:
19822308.
8. Kawase T, Matsuo K, Kashiwase K, et al. HLA mismatch combinations associated with decreased risk of relapse: implications for the molecular mechanism. Blood. 2009; 113:2851–2858. PMID:
18997170.
Article
9. Park M, Koh KN, Kim BE, et al. The impact of HLA matching on unrelated donor hematopoietic stem cell transplantation in Korean children. Korean J Hematol. 2011; 46:11–17.
Article